The Federal Government has responded to the Review of Medicines and Medical Devices Regulation, whereby reforms will be progressively rolled out over the next 2 years. Baker McKenzie senior associate Amy Middlebrook discusses the changes to advertising rules, the approval of medicines and medical devices, and the process for accessing unapproved medicines.

Explore More Insight
View All